The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
3.030
-0.200 (-6.19%)
At close: Dec 5, 2025, 4:00 PM EST
3.040
+0.010 (0.33%)
After-hours: Dec 5, 2025, 7:03 PM EST
The Oncology Institute Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for The Oncology Institute stock have an average target of 6.00, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts an increase of 98.02% from the current stock price of 3.03.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for The Oncology Institute stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +65.02% | Nov 25, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +131.02% | Oct 21, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +98.02% | Jul 16, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $2.5 | Strong Buy | Initiates | $2.5 | -17.49% | Feb 26, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | -33.99% | Jun 16, 2023 |
Financial Forecast
Revenue This Year
505.58M
from 393.41M
Increased by 28.51%
Revenue Next Year
624.58M
from 505.58M
Increased by 23.54%
EPS This Year
-0.56
from -0.71
EPS Next Year
-0.26
from -0.56
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 528.4M | 693.2M | |
| Avg | 505.6M | 624.6M | |
| Low | 488.0M | 591.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 34.3% | 37.1% | |
| Avg | 28.5% | 23.5% | |
| Low | 24.1% | 17.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.54 | -0.18 | |
| Avg | -0.56 | -0.26 | |
| Low | -0.61 | -0.30 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.